We found that MARCH6 is upregulated in primary papillary thyroid cancers (PTCs), and this upregulation contributes to the promotion of thyroid cancer cell proliferation, migration and cell cycle progression. This evidence concerns the gene MARCHF6 and thyroid gland carcinoma.